Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome [NA]

View source ↗

Summary

This document reports on a study of BMS-833923 in two patients with Basal Cell Nevus Syndrome. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-833923

Snippet

Sponsor: University Health Network, Toronto | Conditions: Basal Cell Nevus Syndrome | NA | Status: COMPLETED